Systemic-onset juvenile idiopathic arthritis

Clinical trials for Systemic-onset juvenile idiopathic arthritis explained in plain language.

Never miss a new study

Get alerted when new Systemic-onset juvenile idiopathic arthritis trials appear

Sign up with your email to follow new studies for Systemic-onset juvenile idiopathic arthritis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New hope for kids with severe arthritis: drug shows promise in reducing symptoms and steroid use

Disease control Completed

This study tested a drug called anakinra in 24 children and young adults (ages 2-20) with severe systemic juvenile idiopathic arthritis that did not respond well to steroids. For the first month, half received anakinra and half received a placebo, then all received anakinra for 1…

Matched conditions: SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS

Phase 2/3 • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control

Last updated Jul 11, 2026 00:00 UTC

Systemic-onset juvenile idiopathic arthritis

Get alerted when new Systemic-onset juvenile idiopathic arthritis trials appear

New hope for kids with severe arthritis: drug shows promise in reducing symptoms and steroid use